ACCELLIX LTD – Trademark Portfolio

Entity Type: 99

ACCELLIX LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ACCELLIX. The owner is based in JERUSALEM.

5 SHLOMO MOMO HALEVI ST, 2ND FL PIER B

PO BOX 45409

JERUSALEM 91451 , IL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #88607034
Registered 2019
ACCELLIX
ACCELLIX
Registered 2019

Trademark Classifications

ACCELLIX LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does ACCELLIX LTD have?

ACCELLIX LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does ACCELLIX LTD file in?

ACCELLIX LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ACCELLIX LTD's most well-known trademarks?

ACCELLIX LTD's registered trademark portfolio includes well-known marks such as ACCELLIX. These are among 2 currently registered trademarks in the portfolio.

What is ACCELLIX LTD's trademark registration success rate?

ACCELLIX LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.